Melissa Bersanelli (@Bersa_Dr_Mel) / Twitter
Daniel CASTELLANO | Hospital Universitario 12 de Octubre, Madrid | 12OCTUBRE | Medical Oncology Department
JPM | Free Full-Text | Validation of a Novel Three-Dimensional (3D Fusion) Gross Sampling Protocol for Clear Cell Renal Cell Carcinoma to Overcome Intratumoral Heterogeneity: The Meet-Uro 18 Study | HTML
Intervista Prof. Camillo Porta - YouTube
SCIENTIFIC REPORT 2010 - 2011 - IOV
thumbnail
Camillo Porta - insalutenews.it
Adult Urology | Journal of Urology
Adjuvant therapies for RCC Dr. Camillo Porta S.C. di Oncologia Medica I.R.C.C.S. Policlinico San Matteo, Pavia. - ppt download
Alessandra Bearz's research works | CRO Centro di Riferimento Oncologico di Aviano, Aviano (CRO) and other places
Loop | Camillo Porta
Tumore del rene, quali sono le terapie più attuali - YouTube
Natural History of Malignant Bone Disease in Renal Cancer: Final Results of an Italian Bone Metastasis Survey | PLOS ONE
Loop | Camillo Porta
Untitled
Alessandro RIZZO | Medical Doctor | Ospedale Oncologico "Giovanni Paolo II" di Bari, Bari | IRCCS Bari | Department of Medical Oncology
Sorafenib as first- or second-line therapy in patients with metastatic renal cell carcinoma in a community setting | Future Oncology
Prof. Camillo Porta – Epidemiologia del Carcinoma Renale a Cellule Chiare - YouTube
Docetaxel and prednisone with or without enzalutamide as first-line treatment in patients with metastatic castration-resistant prostate cancer: CHEIRON, a randomised phase II trial - ScienceDirect
Gaetano PEZZICOLI | Medical Doctor | Doctor of Medicine | Università degli Studi di Bari Aldo Moro, Bari | Università di Bari | Dipartimento di Scienze Biomediche ed Oncologia Umana (DIMO)
Giampietro GASPARINI | Managing Director | Oncology
Camillo Porta - Medical Doctor - Università degli Studi di Bari | LinkedIn
Natural History of Malignant Bone Disease in Renal Cancer: Final Results of an Italian Bone Metastasis Survey | PLOS ONE
Le nuove terapie contro il tumore al rene - YouTube
Safety and efficacy of nivolumab for metastatic renal cell carcinoma: real‐world results from an expanded access programme - De Giorgi - 2019 - BJU International - Wiley Online Library
